MedPath

Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin

Phase 3
Terminated
Conditions
Diabetes Mellitus, Type 2
Interventions
Registration Number
NCT03060980
Lead Sponsor
Intarcia Therapeutics
Brief Summary

A Phase 3b, open-label, randomized, multicenter, efficacy, safety, and tolerability study of ITCA 650 compared to Empagliflozin and to Glimepiride, as add-on therapy to Metformin in patients with Type 2 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
245
Inclusion Criteria
  • Diagnosis of T2D 3 months prior to the Screening Visit.
  • Body mass index (BMI) between ≥25 to ≤45 kg/m2 at the Screening Visit.
  • Glycosylated hemoglobin A1c (HbA1c) ≥7.5 and ≤10.5%. 5. 6. On a stable (3 months prior to the Screening Visit) treatment regimen of metformin monotherapy of ≥1500 mg/day).
Exclusion Criteria
  • History of type 1 diabetes.
  • Prior participation in a clinical study involving ITCA 650.
  • Treatment with any GLP-1 receptor agonist (eg, liraglutide, exenatide) within 6 months prior to Screening.
  • History or evidence, within the last 6 months prior to the Screening Visit, of myocardial infarction, coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention), unstable angina, or cerebrovascular accident or stroke.
  • History or evidence of acute or chronic pancreatitis.
  • History of medullary thyroid cancer or a family or personal history of multiple endocrine neoplasia type 2.
  • Treatment of medications that affect GI motility.
  • History of hypersensitivity to exenatide, empagliflozin, or glimepiride or to one of its excipients.
  • Women that are pregnant, lactating, or planning to become pregnant.
  • Chronic (>10 consecutive days) treatment with systemic corticosteroids within 8 weeks prior to screening.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental: Group 1ITCA 650 20/60 mcg/dayITCA 650 20/60 mcg/day
Experimental: Group 2Empagliflozin (oral)Empagliflozin 10 mg/day and 25 mg/day
Experimental: Group 3Glimepiride (oral)Glimepiride 1-6 mg/day
Primary Outcome Measures
NameTimeMethod
Reduction in glycosylated hemoglobin A1cRandomization to 69 weeks

To determine whether ITCA 650 is non-inferior either to empagliflozin or to glimepiride in reducing glycosylated hemoglobin A1c (HbA1c) in patients with T2D following 65 weeks of treatment and 4 weeks of post treatment follow up.

Reduction in weightRandomization to 69 weeks

To determine whether ITCA 650 is non-inferior either to empagliflozin or to glimepiride in reducing weight in patients with T2D following 65 weeks of treatment and 4 weeks of post treatment follow up.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (92)

Anaheim Clinical Trials

🇺🇸

Anaheim, California, United States

Mercury Street Medical Group

🇺🇸

Butte, Montana, United States

Canyon Medical Center, LLC

🇺🇸

Columbus, Ohio, United States

Medication Management, LLC

🇺🇸

Greensboro, North Carolina, United States

Clinical Research Institute of Southern Oregon, PC

🇺🇸

Medford, Oregon, United States

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Research Institute of Dallas

🇺🇸

Dallas, Texas, United States

CookMed Research

🇨🇦

Victoria, British Columbia, Canada

Heartland Research Associates, LLC

🇺🇸

Wichita, Kansas, United States

Catalina Research Institute

🇺🇸

Montclair, California, United States

Colorado Springs Health Partners - East

🇺🇸

Colorado Springs, Colorado, United States

National Research Institute

🇺🇸

Los Angeles, California, United States

Andres Patron, D.O., P.A

🇺🇸

Pembroke Pines, Florida, United States

Harleysville Medical Associates

🇺🇸

Harleysville, Pennsylvania, United States

Clinical Research Advantage

🇺🇸

Evansville, Indiana, United States

HealthCare Research Network

🇺🇸

Hazelwood, Missouri, United States

PMG Research of Wilmington, LLC

🇺🇸

Wilmington, North Carolina, United States

Skyline Medical Center

🇺🇸

Elkhorn, Nebraska, United States

Nature Coast Clinical Reseaerch - Crystal River

🇺🇸

Crystal River, Florida, United States

Radiant Research, Inc.

🇺🇸

Edina, Minnesota, United States

Maine Research Associates

🇺🇸

Auburn, Maine, United States

Medical and Procedural Specialists

🇺🇸

Skokie, Illinois, United States

Columbine Family Practice

🇺🇸

Littleton, Colorado, United States

Providence Clinical Research

🇺🇸

North Hollywood, California, United States

Nevada Family Care

🇺🇸

Henderson, Nevada, United States

Atlanta Center for Medical Research

🇺🇸

Atlanta, Georgia, United States

Oklahoma City Clinic - Midwest City

🇺🇸

Midwest City, Oklahoma, United States

Wells Institute for Health Awareness

🇺🇸

Kettering, Ohio, United States

University of Toledo

🇺🇸

Toledo, Ohio, United States

Advanced Clinical Research

🇺🇸

West Jordan, Utah, United States

Michigan Avenue Internists

🇺🇸

Chicago, Illinois, United States

Preferred Primary Care Phys Inc

🇺🇸

Pittsburgh, Pennsylvania, United States

Ericksen Research and Development, LLC

🇺🇸

Clinton, Utah, United States

Milestone Research

🇨🇦

London, Ontario, Canada

Bluewater Clinical Research Group

🇨🇦

Sarnia, Ontario, Canada

Sound Healthcare

🇺🇸

Port Orchard, Washington, United States

Marin Endocrine Care and Research, Inc.

🇺🇸

Greenbrae, California, United States

Research Center of Fresno, Inc.

🇺🇸

Fresno, California, United States

Palm Harbor Medical Associates

🇺🇸

Palm Harbor, Florida, United States

Indago Research and Health Center, Inc.

🇺🇸

Hialeah, Florida, United States

South Broward Research

🇺🇸

Pembroke Pines, Florida, United States

Primary Care Research Group

🇺🇸

Atlanta, Georgia, United States

HSHS Medical Group DIabetes Research

🇺🇸

Springfield, Illinois, United States

Solaris Clinical Research

🇺🇸

Meridian, Idaho, United States

Community Hospital of Anderson and Madison County, Inc.

🇺🇸

Anderson, Indiana, United States

Overland Park Surgical Specialists, LLL dba College Park Family Care Center

🇺🇸

Overland Park, Kansas, United States

Ehrhardt Clinical Research, LLC

🇺🇸

Belton, Missouri, United States

Scott Research Center

🇺🇸

Laurelton, New York, United States

Down East Medical Associates, PA

🇺🇸

Morehead City, North Carolina, United States

Intend Research

🇺🇸

Norman, Oklahoma, United States

Prestige Clinical Research

🇺🇸

Franklin, Ohio, United States

Preferred Primary Care Physicians

🇺🇸

Uniontown, Pennsylvania, United States

Spartanburg Medical Research

🇺🇸

Spartanburg, South Carolina, United States

Global Medical Research

🇺🇸

DeSoto, Texas, United States

Dallas Diabetes and Endocrine Center

🇺🇸

Dallas, Texas, United States

Sante Clinical Research

🇺🇸

Kerrville, Texas, United States

Health Texas Research Institute

🇺🇸

San Angelo, Texas, United States

Dr. Anil K. Gupta Medicine Professional Corporation

🇨🇦

Toronto, Ontario, Canada

PCP for Life - -Tidwell

🇺🇸

Houston, Texas, United States

Research Institure of South Florida

🇺🇸

Miami, Florida, United States

Palm Research Center, Inc.

🇺🇸

Las Vegas, Nevada, United States

Sentral Clinical Research Services, LLC

🇺🇸

Cincinnati, Ohio, United States

Clinical Trials of Texas, Inc.

🇺🇸

San Antonio, Texas, United States

Victorium Clinical Research Ltd.

🇺🇸

San Antonio, Texas, United States

MacGregor Medical Center

🇺🇸

San Antonio, Texas, United States

Cotton O'Neil Clinical Research Center

🇺🇸

Topeka, Kansas, United States

Family Practice Specialists

🇺🇸

Phoenix, Arizona, United States

Central Phoenix Medical Center

🇺🇸

Phoenix, Arizona, United States

Thomas C. Lenzmeier, M.D., P.C.

🇺🇸

Glendale, Arizona, United States

Fiel Family and Sports Medicine

🇺🇸

Tempe, Arizona, United States

Joslin Diabetes Center

🇺🇸

Boston, Massachusetts, United States

Arizona Community Physicians

🇺🇸

Tucson, Arizona, United States

Pennington Biomedical Research Center

🇺🇸

Baton Rouge, Louisiana, United States

Holston Medical Group, P.C.

🇺🇸

Kingsport, Tennessee, United States

Orange Grove Family Practice

🇺🇸

Tucson, Arizona, United States

Clinical Neuroscience Solutions, Inc.

🇺🇸

Memphis, Tennessee, United States

Albany Medical College

🇺🇸

Albany, New York, United States

Clinical Research of Rock Hill

🇺🇸

Rock Hill, South Carolina, United States

Bailey Clinic

🇨🇦

Red Deer, Alberta, Canada

Fountain Hills Family Practice, P.C.

🇺🇸

Fountain Hills, Arizona, United States

Oklahoma City Clinic - Central

🇺🇸

Oklahoma City, Oklahoma, United States

Lynn Health Science Institute

🇺🇸

Oklahoma City, Oklahoma, United States

American Health Network of Indiana, LLC

🇺🇸

New Albany, Indiana, United States

American Health Research

🇺🇸

Charlotte, North Carolina, United States

Aventiv Research

🇺🇸

Columbus, Ohio, United States

Panacea Clinical Research

🇺🇸

San Antonio, Texas, United States

Juno Research

🇺🇸

Houston, Texas, United States

Crossroads Clinical Research, LLC

🇺🇸

Victoria, Texas, United States

Center for Clinical Trials of Sacramento, Inc.

🇺🇸

Sacramento, California, United States

Denver VA Medical Center

🇺🇸

Aurora, Colorado, United States

DCT-AACT, LLC dba Discovery Clinical Trials

🇺🇸

Austin, Texas, United States

Radiant Research

🇺🇸

Murray, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath